["Allergy, Intolerance": "Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)"]

Performance/Reporting Period

2021

Direct Reference Code

Constrained to 'Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)' SNOMEDCT code

QDM Datatype and Definition (QDM Version 5.5 Guidance Update)

"Allergy Intolerance"

Data elements that meet criteria using this datatype should document the allergy or intolerance and its corresponding value set.

Timing:

The prevalence period references the time from the onset date to the abatement date. Often an abatement date is not present as allergy or intolerance is ongoing.
The author dateTime references the recorded time.

eCQMs using this data element:

QDM Attributes

Prevalance Period is the time from onset dateTime to abatement dateTime.